AKT1 and neoplasm: LncRNA PART1, which serves as a tumor suppressor in gastric cancer, epigenetically silences PDGFB (encoding platelet-derived growth factor B) via PLZF-mediated recruitment of EZH2, thus inhibiting PI3K/Akt signaling activation [89].